Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.
275
Zitationen
8
Autoren
2001
Jahr
Abstract
The high rate of lesion detection, sensitivity, and favorable dosimetry and pharmacokinetics of 64Cu-TETA-OC indicate that it is a promising radiopharmaceutical for PET imaging of patients with neuroendocrine tumors.
Ähnliche Arbeiten
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.
1981 · 14.249 Zit.
The nuclear receptor superfamily: The second decade
1995 · 6.968 Zit.
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
1984 · 5.023 Zit.
Screening λgt Recombinant Clones by Hybridization to Single Plaques in Situ
1977 · 4.664 Zit.
Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.
1984 · 4.208 Zit.